Literature DB >> 2565242

[3H]idazoxan binding at non-alpha 2-adrenoceptors in rabbit adipocyte membranes.

D Langin1, M Lafontan.   

Abstract

The imidazoline ligand, [3H]idazoxan, labels a large population of high-affinity binding sites in rabbit fat cell membranes (Bmax = 1370 +/- 91 fmol/mg protein; KD = 1.6 +/- 0.6 nM) when imidazoline derivatives are used for definition of non-specific binding. [3H]Idazoxan sites are not alpha 2-adrenoceptors as assessed by competition studies which showed that epinephrine, norepinephrine and yohimbine do not inhibit [3H]idazoxan binding. Naphazoline, tramazoline and the Na+/H+ exchange inhibitor, amiloride, completely inhibited [3H]idazoxan binding. The Ki values were 9, 27 and 48 nM, respectively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565242     DOI: 10.1016/0014-2999(89)90707-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Pharmacological characterization of the imidazoline receptor which mediates inhibition of noradrenaline release in the rabbit pulmonary artery.

Authors:  G J Molderings; F Hentrich; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

2.  Effect of a 7-day treatment with idazoxan and its 2-methoxy derivative RX 821002 [correction of RX 821001] on alpha 2-adrenoceptors and non-adrenoceptor idazoxan binding sites in rabbits.

Authors:  M Portillo; M Reverte; D Langin; J M Senard; M A Tran; M Berlan; J L Montastruc
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

3.  [3H]-idazoxan binds with high affinity to two sites on hamster adipocytes: an alpha 2-adrenoceptor and a non-adrenoceptor site.

Authors:  A C MacKinnon; C M Brown; M Spedding; A T Kilpatrick
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

4.  The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain.

Authors:  G Olmos; R Alemany; P V Escriba; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

5.  [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.

Authors:  A Renouard; P S Widdowson; A Cordi
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

6.  Relevance of the use of [3H]-clonidine to identify imidazoline receptors in the rabbit brainstem.

Authors:  G Bricca; J Zhang; H Greney; M Dontenwill; J Stutzmann; A Belcourt; P Bousquet
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

7.  Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.

Authors:  N J Mallard; A L Hudson; D J Nutt
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

8.  Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites.

Authors:  C A Brown; A C Loweth; S A Smith; N G Morgan
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

9.  Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological function.

Authors:  S Diamant; T Eldar-Geva; D Atlas
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

10.  [3H]idazoxan binding to bovine adrenal medullary membranes: identification and pharmacological characterization of I2-imidazoline sites.

Authors:  G J Molderings; L Kundt; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.